Clinical Trial Update: Study Evaluating Genotypes Using Lucentis

View source ↗

Summary

A study evaluating how genetic differences affect response to Lucentis in age-related macular degeneration has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Lucentis (ranibizumab)

Snippet

Sponsor: University of Utah | Conditions: Age-Related Maculopathy | Status: TERMINATED